Revelation Biosciences, Inc., (REVB): Price and Financial Metrics

Revelation Biosciences, Inc., (REVB): $4.24

0.01 (-0.24%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

F

Add REVB to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#298 of 337

in industry

REVB Price/Volume Stats

Current price $4.24 52-week high $69.44
Prev. close $4.25 52-week low $3.34
Day low $4.03 Volume 61,304
Day high $4.37 Avg. volume 370,648
50-day MA $6.25 Dividend yield N/A
200-day MA $18.00 Market Cap 1.14M

REVB Stock Price Chart Interactive Chart >


Revelation Biosciences, Inc., (REVB) Company Bio


Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.


REVB Latest News Stream


Event/Time News Detail
Loading, please wait...

REVB Latest Social Stream


Loading social stream, please wait...

View Full REVB Social Stream

REVB Price Returns

1-mo -43.70%
3-mo -67.00%
6-mo -69.22%
1-year -91.17%
3-year -99.99%
5-year N/A
YTD -42.52%
2024 -96.93%
2023 -92.47%
2022 -98.14%
2021 1.49%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!